Research News
A new study by The George Washington University Cancer Center Technical Assistance and Training Program (GW TAP) highlights the long‑term impact of its Oncology Patient Navigator Training: The Fundamentals, designed to strengthen the cancer care workforce and improve patient outcomes.
Smoking remains the leading preventable cause of cancer and death in the United States. Yet many people trying to quit do so with little support — or with help that isn’t available when they need it most. Researchers at the George Washington University Cancer Center are testing a new approach: an…
Researchers at the GW Cancer Center are combining artificial intelligence, genomics, and large-scale biomedical data to uncover how cancer begins. And how treatments can be better tailored to each patient.
As part of a study, women who watched a 10-minute animated Spanish-language video about cervical cancer learned significantly more than those who only spoke with their doctor. After watching the video, they answered many more questions correctly about cervical cancer and screening.
With a six-year F99/K00 award from the National Cancer Institute, Trace Walker investigates how hidden regions of the genome — called transposable elements — could make ovarian tumors more visible to the immune system and open new doors for treatment.
Scientists uncover how the And-1 protein helps repair UVB-induced DNA damage, offering insights into skin cancer prevention.
In the fight against ovarian cancer, one of the biggest challenges is invisibility. The body’s immune system, usually a vigilant defender, often fails to recognize ovarian tumor cells as dangerous. That’s where GW Cancer Center researcher Kevin Nestler, a PhD candidate in the Chiappinelli Lab,…
The GW Cancer Center and the George Washington University School of Medicine and Health Sciences (SMHS)recently received a $600,000 S10 grant from the National Institutes of Health (NIH) to purchase a state-of-the-art BD FACSDiscover™ S8 CellView spectral flow cytometer and live cell sorter. The…
Glioblastoma is the most aggressive primary brain cancer in adults. Even with treatment, just over 6 percent of patients survive five years or more. But there's good news: GW Cancer Center researchers are bringing hope for more precise, less invasive, and more effective treatments.
Immunotherapy is one of the most transformative advancements in cancer care today. Unlike chemotherapy or radiation, which work by directly killing cancer cells, immunotherapy strengthens or modifies the body’s own immune system so that it can detect and destroy cancer cells. It represents a major…